REM-i Platform for Oncology Research
Tumor Heterogeneity, Rare Cancer Cell Analysis
Research-Use OnlyActive
Key Facts
Indication
Tumor Heterogeneity, Rare Cancer Cell Analysis
Phase
Research-Use Only
Status
Active
Company
About Deepcell
Deepcell is a private, venture-backed biotech company pioneering the field of 'morpholomics'—using AI to analyze and sort living cells based on their visual appearance. Its core product, the REM-i platform, integrates custom microfluidics, high-resolution imaging, and a self-supervised AI foundation model to provide a non-destructive, label-free workflow for single-cell analysis and enrichment. The company is targeting the research tools and diagnostics markets, with strategic partnerships in place, and appears to be in an early revenue stage as it commercializes its platform for academic and biopharma applications.
View full company profile